C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2006
11/28/2006	US7141409 Hyaluronan synthase gene and uses thereof
11/28/2006	US7141408 live vector vaccine; removal of sole dependence on catalytic balanced lethal maintenance systems; plasmid partition system prevents random segregation; enhanced inheritance and stability; genetic engineering; antibiotic resistance
11/28/2006	US7141405 Hepatotropic flavivirus which is phylogenetic to human hepatitis C virus (GBV-B); drug screening
11/28/2006	US7141403 DNA sequences that code for polypeptides having hydrolase activity, used for detergent and textile applications
11/28/2006	US7141402 gene that code for polypeptides having hydrolase activity, produced by genetic engineering and used for producing oligosaccharides
11/28/2006	US7141401 Protein complex for use in the treatment and prevention of lipid, cell proliferation, apoptosis, optic neuropathy, and inflammatory disorders
11/28/2006	US7141394 Using isobutyl-C-galactoside (IBCG) as a functional replacement of isopropylthiogalactoside (IPTG) in inducing expression of proteins under control of the lactose operon promoter; functions as mimic or substitute for galactose
11/28/2006	US7141392 Latent fusion protein
11/28/2006	US7141391 Monkey and canine melanin concentrating hormone receptors
11/28/2006	US7141390 Polynucleotide encoding human interleukin-17 receptor like molecule
11/28/2006	US7141389 Chromosome DNA coding for human hepatocyte growth factor
11/28/2006	US7141388 Nucleotide sequences for transcriptional regulation in corynebacterium glutamicum
11/28/2006	US7141383 EDG8 receptor, its preparation and use
11/28/2006	US7141379 Recombinant DNA formed by ligating; gene expression; suppressing proliferation; medicine/drugs
11/28/2006	US7141377 Process for discrimination of nucleic acid sequence variants
11/28/2006	US7141376 Carrier tests for polycystic kidney disease in the cat
11/28/2006	US7141375 Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor
11/28/2006	US7141373 Method of haplotype-based genetic analysis for determining risk for developing insulin resistance and coronary artery disease
11/28/2006	US7141367 Nucleotide sequences coding polypeptide for use in the treatment of inflammation and respiratory disorders
11/28/2006	US7141366 Surface display of selenocysteine-containing peptides
11/28/2006	US7141365 Methods for diagnosing a mucin production associated disease condition
11/28/2006	US7141244 Helicobacter pylori proteins useful for vaccines and diagnostics
11/28/2006	US7141243 gM-negative EHV-mutants without heterologous elements
11/28/2006	US7141242 Hepatitis B virus surface antigen mutant and methods of detection thereof
11/28/2006	US7141240 Glucose-dependent insulin-secreting cells transfected with a nucleotide sequence encoding GLP-1
11/28/2006	CA2311395C Flavivirus expression and delivery system
11/28/2006	CA2282394C Retroviral vectors, methods for their preparation and their use for gene transfer into cd4-positive cells
11/28/2006	CA2257141C Sample delivery module for particle acceleration apparatus
11/28/2006	CA2226968C Novel monoclonal antibody, and immunological assay of e-d-dimer and e-dd/e complex
11/28/2006	CA2208095C Generation of human insulin
11/28/2006	CA2123354C Thermostable nucleic acid polymerase
11/28/2006	CA2114636C Recombinant plant viral nucleic acids
11/28/2006	CA2076345C Transgenic animals, cells and cell lines therefrom, and their use
11/28/2006	CA2052792C Method and composition for increasing sterol accumulation in higher plants
11/28/2006	CA2035888C Nucleic acid coding for human testicular angiotensin (eca) conversion enzyme, its applications, in particular for in vitro screening of this enzyme in the organism
11/28/2006	CA2026915C Stem cell factor
11/28/2006	CA1341516C Preparation of factor x111a by gene manipulation
11/23/2006	WO2006125065A2 Resistance to soybean aphid in early maturing soybean germplasm
11/23/2006	WO2006124820A2 Materials and methods for regulating blood flow
11/23/2006	WO2006124779A2 Methods for production of chitin and chitosan
11/23/2006	WO2006124777A2 Post-transcriptional regulation of gene expression in plants
11/23/2006	WO2006124686A2 Modulation of stat 6 expression for the treatment of airway hyperresponsiveness
11/23/2006	WO2006124678A2 Corn plants and seed enhanced for asparagine and protein
11/23/2006	WO2006124667A2 Compositions and methods for modulating immune responses
11/23/2006	WO2006124626A2 Inhibition of the 44 kilodalton isoform of pim-1 kinase restores apoptosis induced by chemotherapeutic drugs in cancer cells
11/23/2006	WO2006124022A1 Microarray gene expression profiling in subtypes of clear cell renal cell carcinoma
11/23/2006	WO2006124001A1 Transposition of maize ac/ds elements in vertebrates
11/23/2006	WO2006123867A1 siRNA FOR INHIBITING IL-6 EXPRESSION AND COMPOSITION CONTAINING THEM
11/23/2006	WO2006123829A1 ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
11/23/2006	WO2006123827A1 Method for amelioration of disease condition induced by mood disorder
11/23/2006	WO2006123817A1 Method for delivering nucleic acid and device for delivering nucleic acid
11/23/2006	WO2006123800A2 Rna interference induction element and use thereof
11/23/2006	WO2006123781A1 Methods for recovering microorganism and nucleic acid using fine particle and kit to be used for the methods
11/23/2006	WO2006123778A1 Method for producing cadaverine carbonate, and method for producing polyamide using the same
11/23/2006	WO2006123745A1 Process for production of l-serine derivative and enzyme used in the process
11/23/2006	WO2006123737A1 High molecular compound for medical material and biochip substrate using such high molecular compound
11/23/2006	WO2006123647A1 Method for detection of gene
11/23/2006	WO2006123644A1 Int6 PROTEIN INVOLVED IN HYPOXIA STRESS INDUCTION AND USE THEREOF
11/23/2006	WO2006123555A1 Transformation method and transfection or infection method for cell
11/23/2006	WO2006123537A1 Novel endoribonuclease
11/23/2006	WO2006123445A1 Method of displaying protein
11/23/2006	WO2006123423A1 Primer for detecting fungus of the genus fusarium
11/23/2006	WO2006123295A2 Dna fragments, primers, kits, and methods for amplification the detection and identification of clinically relevant candida species
11/23/2006	WO2006123248A2 Improved methods and devices for delivering a therapeutic product to the ocular sphere of a subject
11/23/2006	WO2006123097A2 Improved expression elements
11/23/2006	WO2006123004A1 Endothelized artificial matrix comprising a fibrin gel, which is a superproducer of proangiogenic factors
11/23/2006	WO2006122972A1 Interferon-beta gene therapy using an improved, regulated expression system
11/23/2006	WO2006122971A2 Treatment of disease using an improved regulated expression system
11/23/2006	WO2006122650A2 Isolated aqdecay photoprotein and use thereof
11/23/2006	WO2006122542A2 Non-viral vector system for transporting nucleic acid into the lungs
11/23/2006	WO2006122512A1 Fusion proteins comprising protein transduction domain, auxiliary protein and bioactive protein, their production and uses
11/23/2006	WO2006122464A1 An oligonucleotide or its functional homologue, a composition comprising the same and a method for treating b cell neoplasm
11/23/2006	WO2006122463A1 Oligonucleotides or their functional homologues, a composition comprising the same and a method of treating b cell neoplasm
11/23/2006	WO2006122443A1 The method for knocking-out the fish gene
11/23/2006	WO2006122442A1 Piggybac as a tool for genetic manipulation and analysis in vertebrates
11/23/2006	WO2006122407A1 Diagnostic applications of micro arrays in organ transplantation
11/23/2006	WO2006122401A1 Negative regulation of nk cell functions by eat-2, a sap-related adaptor expressed in innate immune cells
11/23/2006	WO2006122363A1 Therapeutic agents and targets
11/23/2006	WO2006122354A1 Sequential cloning system
11/23/2006	WO2006102188A3 Methods and compositions involving the s-ship promoter
11/23/2006	WO2006099615A9 Adenoviral fiber exchange shuttle system
11/23/2006	WO2006099037A3 A sporadic tumor mouse model for drug discovery
11/23/2006	WO2006098929B1 Chimeric virus for the treatment of cancer
11/23/2006	WO2006096441A3 Reagents, methods and systems to suppress phospholamban expression
11/23/2006	WO2006096063B1 Construct and method for screening, selection and identification of stress factors
11/23/2006	WO2006090241A3 Method of creating or selecting recombinant genes
11/23/2006	WO2006088833A3 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor
11/23/2006	WO2006084705A3 Novel gene sts 06
11/23/2006	WO2006084704A3 Novel gene sts 01
11/23/2006	WO2006084703A3 Novel gene sts 24
11/23/2006	WO2006083410A3 Recombinant microorganisms for increased production of organic acids
11/23/2006	WO2006079655A3 Plants having increased yield and a method for making the same
11/23/2006	WO2006076296A3 A non-naturally occurring animal that expresses an untranslated non-coding rna
11/23/2006	WO2006073839A3 Acid fungal proteases
11/23/2006	WO2006069201A3 Plant stress tolerance from modified ap2 transcription factors
11/23/2006	WO2006067465A3 Cancer treatment
11/23/2006	WO2006063067A3 Novel tnf receptor regulatory domain
11/23/2006	WO2006060719A3 Use of endosialin binding proteins to isolate endosialin positive cells
11/23/2006	WO2006055778A3 Immunoglobulin variable region cassette exchange
11/23/2006	WO2006047250A3 Use of apoptosis inhibiting compounds in degenerative neurological disorders

1 ... 1703 1704 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 ... 4023